Venetoclax–azacitidine as a bridge to transplant in pediatric relapsed/refractory acute myeloid leukemia: A real-world experience

Background: Survival outcomes in pediatric acute myeloid leukemia (AML) have improved significantly; however, prognosis for relapsed or refractory (R/R) disease remains dismal. This study evaluates real-world outcomes of Venetoclax-Azacytidine (Ven–Aza) as a bridge to transplant in children with R/R...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Sunisha Arora, Anuj Singh, Sohini Chakraborty, Vaibhav Chadha, Satyendra Batra, Parminder Pal Singh, Neha Rastogi Panda, Shrinidhi Nathany, Madhur Arora, Anusha Swaminathan, Surbhi Pokhriyal, Aastha Gupta, Surbhi Singh, Bharti Sharma, Rahul Bhargava, Vikas Dua
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	Elsevier 2026-06-01
سلاسل:	Pediatric Hematology Oncology Journal
الموضوعات:	Pediatric AML Azacytidine Venetoclax Salvage
الوصول للمادة أونلاين:	http://www.sciencedirect.com/science/article/pii/S2468124526000355
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!